My research is dedicated to developing new drugs and therapies for retinal vascular diseases and expanding the understanding of them. The ever-evolving challenges of research fuel my curiosity and bring a deep sense of accomplishment. I aim to integrate emerging technologies like AI and gene therapy to revolutionize diagnostics and treatment protocols. I am also committed to contributing to a dynamic, collaborative scientific community focused on mitigating the impact of retinal diseases worldwide. Valuing the research opportunity provided by Keio University, I am resolved to persistently apply my efforts toward these endeavors.